Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein
Korro Bio, Inc. has designated KRRO-111 as its development candidate for the potential treatment of Alpha-1 Antitrypsin Deficiency (AATD). In preclinical studies, KRRO-111 demonstrated greater ...